Abzu
Biotechnology ResearchHovedstaden, Denmark11-50 Employees
Abzu is a biotechnology research company focused on understanding diseases and guiding drug design through computational methods. Its work relies on an explainable artificial intelligence framework, the QLattice, which underpins its approach to translating complex data into actionable insights. Founded in 2018, Abzu positions itself as a partner for pharma, biotech, and research institutions, helping to accelerate R&D through in silico analysis and design. Headquartered in the Copenhagen area of Denmark, Abzu also maintains an office in Barcelona, reflecting its European footprint. The company operates as a small to mid-sized organization within the biotechnology research sector, serving customers across pharmaceutical and academic settings with its AI-enabled research capabilities.